InsiderGauge
Checking updates…
Dashboard

Mpm Bioventures 2018, L.P.insider trades

In SEC Form 4 filings, Mpm Bioventures 2018, L.P. is listed as 10% owner of Entrada Therapeutics, Inc. (TRDA). In the last 90 days, Mpm Bioventures 2018, L.P. sold $3.60M of Entrada Therapeutics, Inc. (TRDA) on the open market and bought none.

Companies and roles

CompanyRoleTransactionsLast filed
TRDAEntrada Therapeutics, Inc.10% owner12Sep 9

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-26

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
TRDAEntrada Therapeutics, Inc.Sep 9Sep 9S28,837$7.13Sale −$205,6083,885,115NoForm 4
TRDAEntrada Therapeutics, Inc.Sep 8Sep 9S192,500$7.41Sale −$1,426,4253,913,952NoForm 4
TRDAEntrada Therapeutics, Inc.Sep 4Sep 9S38,500$7.11Sale −$273,7354,106,452NoForm 4
TRDAEntrada Therapeutics, Inc.Sep 3Sep 3S32,263$7.17Sale −$231,3264,144,952NoForm 4
TRDAEntrada Therapeutics, Inc.Sep 2Sep 3S25,131$7.19Sale −$180,6924,177,215NoForm 4
TRDAEntrada Therapeutics, Inc.Sep 1Sep 3S29,088$7.06Sale −$205,3614,202,346NoForm 4
TRDAEntrada Therapeutics, Inc.Aug 31Aug 31S44,259$6.99Sale −$309,3704,231,434NoForm 4
TRDAEntrada Therapeutics, Inc.Aug 28Aug 31S3,733$7.01Sale −$26,1684,275,693NoForm 4
TRDAEntrada Therapeutics, Inc.Aug 27Aug 31S38,922$7.20Sale −$280,2384,279,426NoForm 4
TRDAEntrada Therapeutics, Inc.Aug 26Aug 26S14,569$7.06Sale −$102,8574,318,348NoForm 4
TRDAEntrada Therapeutics, Inc.Aug 25Aug 26S26,522$7.54Sale −$199,9764,332,917NoForm 4
TRDAEntrada Therapeutics, Inc.Aug 24Aug 26S21,623$7.34Sale −$158,7134,359,439NoForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.